Similar articles for PMID: 11264379

Year	Number of Results
1940	1
1953	1
1955	2
1962	1
1979	1
1986	1
1987	1
1988	6
1989	5
1990	7
1991	11
1992	19
1993	19
1994	23
1995	30
1996	16
1997	20
1998	21
1999	10
2000	15
2001	20
2002	15
2003	11
2004	11
2005	14
2006	10
2007	17
2008	15
2009	10
2010	10
2011	12
2012	9
2013	11
2014	4
2015	9
2016	5
2017	6
2018	4
2019	4
2020	3
2021	1
2022	1
2024	0

1

Ability of the V3 loop of simian immunodeficiency virus to serve as a target for antibody-mediated neutralization: correlation of neutralization sensitivity, growth in macrophages, and decreased dependence on CD4.

Means RE, Matthews T, Hoxie JA, Malim MH, Kodama T, Desrosiers RC. Means RE, et al. J Virol. 2001 Apr;75(8):3903-15. doi: 10.1128/JVI.75.8.3903-3915.2001. J Virol. 2001. PMID: 11264379 Free PMC article.

2

Differential CD4/CCR5 utilization, gp120 conformation, and neutralization sensitivity between envelopes from a microglia-adapted human immunodeficiency virus type 1 and its parental isolate.

Martín J, LaBranche CC, González-Scarano F. Martín J, et al. J Virol. 2001 Apr;75(8):3568-80. doi: 10.1128/JVI.75.8.3568-3580.2001. J Virol. 2001. PMID: 11264346 Free PMC article.

3

CD4 independence of simian immunodeficiency virus Envs is associated with macrophage tropism, neutralization sensitivity, and attenuated pathogenicity.

Puffer BA, Pöhlmann S, Edinger AL, Carlin D, Sanchez MD, Reitter J, Watry DD, Fox HS, Desrosiers RC, Doms RW. Puffer BA, et al. J Virol. 2002 Mar;76(6):2595-605. doi: 10.1128/jvi.76.6.2595-2605.2002. J Virol. 2002. PMID: 11861825 Free PMC article.

4

A replication-competent, neutralization-sensitive variant of simian immunodeficiency virus lacking 100 amino acids of envelope.

Johnson WE, Morgan J, Reitter J, Puffer BA, Czajak S, Doms RW, Desrosiers RC. Johnson WE, et al. J Virol. 2002 Mar;76(5):2075-86. doi: 10.1128/jvi.76.5.2075-2086.2002. J Virol. 2002. PMID: 11836385 Free PMC article.

5

Assorted mutations in the envelope gene of simian immunodeficiency virus lead to loss of neutralization resistance against antibodies representing a broad spectrum of specificities.

Johnson WE, Sanford H, Schwall L, Burton DR, Parren PW, Robinson JE, Desrosiers RC. Johnson WE, et al. J Virol. 2003 Sep;77(18):9993-10003. doi: 10.1128/jvi.77.18.9993-10003.2003. J Virol. 2003. PMID: 12941910 Free PMC article.

6

Characterization of neutralization epitopes of simian immunodeficiency virus (SIV) recognized by rhesus monoclonal antibodies derived from monkeys infected with an attenuated SIV strain.

Cole KS, Alvarez M, Elliott DH, Lam H, Martin E, Chau T, Micken K, Rowles JL, Clements JE, Murphey-Corb M, Montelaro RC, Robinson JE. Cole KS, et al. Virology. 2001 Nov 10;290(1):59-73. doi: 10.1006/viro.2001.1144. Virology. 2001. PMID: 11883006 Free article.

7

V3 loop truncations in HIV-1 envelope impart resistance to coreceptor inhibitors and enhanced sensitivity to neutralizing antibodies.

Laakso MM, Lee FH, Haggarty B, Agrawal C, Nolan KM, Biscone M, Romano J, Jordan AP, Leslie GJ, Meissner EG, Su L, Hoxie JA, Doms RW. Laakso MM, et al. PLoS Pathog. 2007 Aug 24;3(8):e117. doi: 10.1371/journal.ppat.0030117. PLoS Pathog. 2007. PMID: 17722977 Free PMC article.

8

Simian immunodeficiency virus mutants resistant to serum neutralization arise during persistent infection of rhesus monkeys.

Burns DP, Collignon C, Desrosiers RC. Burns DP, et al. J Virol. 1993 Jul;67(7):4104-13. doi: 10.1128/JVI.67.7.4104-4113.1993. J Virol. 1993. PMID: 8510218 Free PMC article.

9

Cryptic nature of a conserved, CD4-inducible V3 loop neutralization epitope in the native envelope glycoprotein oligomer of CCR5-restricted, but not CXCR4-using, primary human immunodeficiency virus type 1 strains.

Lusso P, Earl PL, Sironi F, Santoro F, Ripamonti C, Scarlatti G, Longhi R, Berger EA, Burastero SE. Lusso P, et al. J Virol. 2005 Jun;79(11):6957-68. doi: 10.1128/JVI.79.11.6957-6968.2005. J Virol. 2005. PMID: 15890935 Free PMC article.

10

Alanine substitution of two arginines in amino terminus of V3 of SIV disrupts CD4 binding whereas a similar replacement of two amino acids, lysine and arginine, in the carboxyl half of V3 prevents binding of a neutralizing monoclonal antibody.

Javaherian K, Zuchowski L, Clark FT. Javaherian K, et al. AIDS Res Hum Retroviruses. 1995 Sep;11(9):1101-5. doi: 10.1089/aid.1995.11.1101. AIDS Res Hum Retroviruses. 1995. PMID: 8554907

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

399 results

Results by year